Wed.Jan 29, 2025

article thumbnail

Opinion: When your child can’t walk and it could be polio

STAT

My son was 5 years old when he climbed out of bed and landed on the floor. He was always a teaser. “C’mon, silly,” I said. “Time to get ready for school.” “Mommy,” Aaron said, very puzzled. “I can’t feel my legs.

Vaccines 136
article thumbnail

Q&A: The Rise of AI in Alleviating Health Care Workforce Challenges

Drug Topics

Scott Nelson, PharmD, MS, FAMIA, ACHIP, discussed the increasingly crucial role artificial intelligence has played in streamlining pharmacy services.

126
126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmacy Focuses on Prevention for the Community in Owasso, Oklahoma

Pharmacy Times

Kathy Campbell, PharmD, shares her experiences helping 4 generations of patients.

123
123
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Montefiore Health System is partnering with Amazon One Medical to open up access to primary and specialty care in New Yorks Westchester County and surrounding areas.

110
110
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Common Osteoporosis Treatments May Offer Protection Against COVID-19

Pharmacy Times

Through similar targeting of the RdRp enzyme, these treatments could offer groundbreaking new options for patients with COVID-19 if proven effective in real-world trials.

120
120
article thumbnail

Ozempic approved for chronic kidney disease patients

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. Another busy day, so let’s get straight into the news.

101
101

More Trending

article thumbnail

Micronutrient Deficiencies Common Among Patients With Type 2 Diabetes

Drug Topics

A recent systematic review and meta-analysis found that almost half of all patients with type 2 diabetes were deficient in multiple micronutrients.

98
article thumbnail

Iron Deficiency Is Prevalent in Patients With Non-Anemia, Non-Dialysis-Dependent-CKD

Pharmacy Times

The authors note that transferrin saturation levels may be a modifiable risk factor of chronic kidney disease (CKD) progression and all-cause mortality.

103
103
article thumbnail

Q&A: Raising Awareness About Maternity Care Deserts Among Community Pharmacists

Drug Topics

Natalie DiPietro Mager, PharmD, PhD, discusses the role of community pharmacy in maternal health.

article thumbnail

FDA Accepts Review of Biologics License Application for AVT05, a Biosimilar Candidate for Golimumab

Pharmacy Times

This marks the first US biologic license application filing acceptance for a biosimilar candidate to golimumab.

FDA 97
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Gestational Age Associated with Pain Among Very Preterm Infants

Drug Topics

Researchers analyzed liveborn infant data from January 2020 to June 2024 to determine prevalence, cause, and treatment strategies for pain among preterm infants.

98
article thumbnail

FDA Grants Orphan Drug Designation to ZL-1310 for Treatment of Small Cell Lung Cancer

Pharmacy Times

Preliminary phase 1 trial results demonstrate that patients with small cell lung cancer generated early clinical activity after being administered ZL-1310.

FDA 95
article thumbnail

Ozempic is first GLP-1 drug FDA-approved for kidney disease

pharmaphorum

Novo Nordisk's Ozempic has become the first drug in the GLP-1 class to be cleared to prevent worsening kidney disease in type 2 diabetics

FDA 94
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Abridge launched a new generative AI product for emergency care and its currently in use at several health systems, including Deaconess Health System, Emory Healthcare, Johns Hopkins Medicine and UChicago Medicine.

86
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Lyfegen partners EVERSANA on pricing, access resource

pharmaphorum

Lyfegen and EVERSANA have joined forces to help pharma companies navigate an increasingly complex global drug pricing and access environment

90
article thumbnail

STAT+: Biotech accelerator Curie.Bio raises $340 million for a new seed fund

STAT

Curie.Bio, the biotech accelerator and investment firm started by Alexis Borisy and Zach Weinberg, has raised another $340 million to invest in startups. Borisy and Weinberg’s firm was created to upend the biotech financing model , offering both capital and expert assistance to founders seeking on option outside of traditional VC funding. The idea has resonated with venture capitalists — several of whom have invested in Curie.Bio — and startups.

94
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Using personalized data and predictive algorithms, the platform generates a custom care plan, which can be analyzed against personal financial data, insurance coverage and healthcare trends to preserve family savings throughout the care journey.

article thumbnail

CD5 CAR-T Cell Therapy Receives FDA Orphan Drug Designation for T-Cell Lymphoma

Pharmacy Times

MB-105 is a first-in-class CD5-targeted chimeric antigen receptor (CAR) T-cell therapy for the treatment of relapsed or refractory CD5-positive T-cell lymphoma.

FDA 82
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Systole exclusively provides virtual group care to women with heart disease. In its six-week, hour-long sessions, patients receive information on heart disease, get care from a cardiologist and support each others' journeys through the disease.

80
article thumbnail

Fedratinib Shows Efficacy in Previously Treated Myelofibrosis, Some Patients With Ruxolitinib Failure

Pharmacy Times

Data indicates fedratinibs role as an effective second-line treatment in patients with myelofibrosis who have been previously treated with a JAK inhibitor, such as ruxolitinib, though more research is necessary.

73
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

While major payers skipped out on this years event, health tech companies, health systems and insurtechs all made appearances to share their latest updates with investors.

80
article thumbnail

Will European PFAS ban disrupt pharma supply chains?

Pharmaceutical Technology

A proposed ban on PFAS chemicals is being challenged over concerns about potential supply chain disruption in the pharmaceutical industry.

72
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Plans available through Healthcare.gov denied an average of 20% of claims in 2023, according to a new analysis from KFF.

73
article thumbnail

Kansas Reports Historic Numbers of Active Tuberculosis Cases

Pharmacy Times

Pharmacists can have informed discussions with patients about the importance of adherence to tuberculosis (TB) treatment regimens, especially for patients with active TB.

69
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

The academic health systems' vision, NC Children's, will be a private nonprofit entity featuring a 500-bed hospital, an outpatient care center and a behavioral health center.

article thumbnail

Troubled 23andMe is exploring a sale of the business

pharmaphorum

Genetic testing specialist 23andMe has launched a strategic review that could result in a sale of the company.

66
article thumbnail

Mitochondrial Dysfunction Present in Visceral Adipose Tissue in Patients With Obesity-Related MASH

Pharmacy Times

The authors note that this may cause disruptions in the metabolic stability of lipid processing and storage, impacting the liver and accelerating damaging adaptative responses.

65
article thumbnail

The future is LIVE marketing – and that matters more than ever

pharmaphorum

Discover why live marketing is the future, and why it matters now more than ever. Explore the latest trends, strategies, and tips for successful live marketing campaigns.

64
article thumbnail

5 Key Challenges and Opportunities for Medically Integrated Dispensing Pharmacies in 2025

Pharmacy Times

In 2025, medically integrated dispensing pharmacies face significant challenges, including low reimbursements, restrictive pharmacy benefit manager practices, complex therapies, regulatory barriers such as the Stark delivery law, and the Inflation Reduction Act's financial implications, necessitating urgent advocacy, reform, and collaboration to sustain equitable, patient-centered cancer care.

65
article thumbnail

Positive topline results announced in phase 2 Alcohol Use Disorder study

Pharmafile

Beckley Psytech Ltd, a clinical-stage biopharmaceutical company that specialises in the production of accessible medicines for mental health conditions, has announced positive results for the phase 2a study into BPL-003 in patients with moderate-to-severe Alcohol Use Disorder (AUD). The study, labelled NCT05674929, was conducted at Kings College London and Clerkenwell Health, both UK.

article thumbnail

Best Practices in Switching PBC Therapies

Pharmacy Times

Panelists discuss how clinicians may transition patients to newer agents due to factors such as inadequate biochemical response, tolerability issues (particularly pruritus), or patient preference, while carefully considering the need for washout periods based on each drug's pharmacokinetics and mechanism of action.

65
article thumbnail

Enhancing spectroscopy analysis with machine learning

European Pharmaceutical Review

Researchers have developed and optimised a novel sensing strategy for isomer discrimination by combining advanced spectroscopy with machine learning. The approach is based on surface-enhanced Raman scattering (SERS) substrates (ie, plasmonic platforms). Montes-Garca et al. explained that they fabricated advanced SERS substrates made of quasi-spherical gold nanoparticles (Au NPs) synthesised via a seeded growth method.

59
article thumbnail

Monitoring Patients Transitioning From Obeticholic Acid

Pharmacy Times

Panelists discuss how transitioning patients from obeticholic acid to seladelpar or elafibranor requires close monitoring of liver biochemistry, pruritus severity, medication adverse effects, and quality of life measures while providing clear patient education about expected timeline for symptom improvement and potential adjustment periods.

65